JZJinlu Zhao

Jinlu Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jinlu Zhao has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comprehensive analysis of primary thyroid lymphoma: a case report and review of diagnostic and treatment protocols

    by Jin-Lu Zhao, Jun-Hao Zhao, Xiao-Yong Yang, Xue Guan, Yu-Cheng Jia, Yi-Hao Cai, Rui-Sheng Ge, Kuo Miao, He Wang, Shao-Dong Cao, et al.

    Background: In clinical practice, primary thyroid lymphoma (PTL) is a rare malignant neoplasm, making up only 2–5% of all thyroid malignancies. The most common type of PTL is diffuse large B-cell lymphoma (DLBCL), which accounts for about 60–70% of thyroid lymphomas. Typically, patients present with a painless progressive growth of neck masses, accompanied by local compressive symptoms. Currently, accurate diagnosis and treatment selection for PTL are significantly challenging. Research on PTL involving the pyramidal lobe is relatively scarce, resulting in persistently high rates of misdiagnosis and missed diagnosis. Additionally, uncertainties remain regarding the optimal surgical resection range and chemotherapy dosage for such combined lesions. Case Description: Here, we report a case involving a 66-year-old woman with a 16-year history of hypothyroidism, who presented with typical compression symptoms. After surgical resection, the patient was diagnosed with DLBCL of the right thyroid and pyramidal lobe, based on pathology and then underwent rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) chemotherapy. Following treatment, there was no recurrence or metastasis observed during the 6-month follow-up period. Conclusions: This case proves that the incidence of pyramidal lobe lymphoma involvement in PTL is extremely low and prone to missed diagnosis. Perioperatively, we should strengthen the awareness of this issue to reduce the possibility of misdiagnosis and missed diagnosis. Meanwhile, with a clear pathological diagnosis, a reasonable and effective chemotherapy regimen can achieve excellent therapeutic effects. Local symptoms can also be effectively alleviated through surgical resection.


  • Open Access

    The High‐Quality Genome Sequencing and Analysis of Red Raspberry (Rubus idaeus L.)

    by Haopeng Zhang, Weihua Li, Guodong Li, Jiaren Liu, Hongsheng Chen, Chunpeng Zhang, Jinlu Zhao, Zhicheng Zhang, Qiang Lv, Yan Zhang, et al.

    Red raspberry (Rubus idaeus L.), which is an important nutritional source for human health, belongs to fruit crops of the Rosaceae family. Here, we used Pacific Biosciences single‐molecule real‐time (SMRT) sequencing and high‐throughput chromosome conformation capture (Hi‐C) sequencing technologies to assemble genomes and reported a high‐quality Rubus idaeus L. (DNS‐1) genome with 321.29 Mb assembled into seven chromosomes. The LAI score of the DNS‐1 genome assembly was 21.32, belonging to gold quality. Approximately 52.3% of the assembly sequences were annotated as repetitive sequences, and 24.15% were composed of long terminal repeat elements. A total of 29,814 protein‐coding genes and 2474 pseudogenes were predicted in DNS‐1. We characterized the complete genomes of DNS‐1 and compared them to those of seven other species. We found that 652 gene families were unique to DNS‐1 and they were shaped from an ancestor. There were 1000 and 5193 gene families that expanded and contracted in the DNS‐1 genome. The Rubus idaeus L. genome can be used to understand the structure and evolution of Rosaceae genomes and can be developed to identify genes controlling important traits and improve breeding work.


  • Thyroid organoids: Advances and applications

    by Jinlu Zhao, Yi Ren, Zhenzhong Ge, Xingyu Zhao, Wang Li, He Wang, Meng Jiang

    Organoids are derived from stem cells under three-dimensional culture conditions through self-assembly, and they can recapitulate the structural and functional characteristics of organs in vivo during culture. Organoids can be generated from both normal and malignant tissues. Those derived from normal tissues are widely used in the field of regenerative medicine. Meanwhile, tumour-derived organoids retain the phenotypic heterogeneity and atypia of the primary tumour, thereby providing a reliable in vitro model for the study of tumour pathogenesis and treatment. The thyroid gland is one of the most important endocrine organs regulating the body’s energy metabolism and growth; however, it is also associated with a high incidence of malignancy. Organoid is an effective tool for thyroid research. Thyroid tumour-derived organoids can inherit the histopathological properties of primary tumours, and thyroid tissue-derived organoids can form follicular structures and secrete thyroid hormones. The above characteristics of organoids provide a reliable way to study the mechanism of thyroid genesis and tumour development in vitro. In this review, we focus on current knowledge and strategies for the establishment of thyroid organoids in thyroid regeneration and tumour research aiming to increase our understanding of the pathogenesis of thyroid tumours and the regenerative treatment of patients with hypothyroidism. Organoids are derived from stem cells under three-dimensional culture conditions through self-assembly, and they can recapitulate the structural and functional characteristics of organs in vivo during culture. Organoids can be generated from both normal and malignant tissues. Those derived from normal tissues are widely used in the field of regenerative medicine. Meanwhile, tumour-derived organoids retain the phenotypic heterogeneity and atypia of the primary tumour, thereby providing a reliable in vitro model for the study of tumour pathogenesis and treatment. The thyroid gland is one of the most important endocrine organs regulating the body’s energy metabolism and growth; however, it is also associated with a high incidence of malignancy. Organoid is an effective tool for thyroid research. Thyroid tumour-derived organoids can inherit the histopathological properties of primary tumours, and thyroid tissue-derived organoids can form follicular structures and secrete thyroid hormones. The above characteristics of organoids provide a reliable way to study the mechanism of thyroid genesis and tumour development in vitro. In this review, we focus on current knowledge and strategies for the establishment of thyroid organoids in thyroid regeneration and tumour research aiming to increase our understanding of the pathogenesis of thyroid tumours and the regenerative treatment of patients with hypothyroidism.


  • Open Access

    Overexpression of CDCP1 is Associated with Poor Prognosis and Enhanced Immune Checkpoints Expressions in Breast Cancer

    by Jinlu Zhao, Jie Mei, Fengxu Wang, Xinyuan Zhao, Yi Ren, Xingyu Zhao, Wang Li, Erli Gao

    CUB-domain containing protein 1 (CDCP1) is a transmembrane protein acting as an effector of SRC family kinases, which play an oncogenic role in multiple human cancers. However, its clinical and immune correlations in breast cancer (BrCa) have not been explored. To define the expression, prognostic value, and potential molecular role of CDCP1 in BrCa, multiple public datasets, and an in-house cohort were used. Compared with paratumor tissue, CDCP1 was remarkably upregulated in the tumor tissues at both mRNA and protein levels. In the in-house cohort, CDCP1 protein expression was related to several clinicopathological parameters, including age, ER status, PR status, molecular type, and survival status. Kaplan–Meier analysis and Cox regression analysis exhibited that CDCP1 was an important prognostic biomarker in BrCa. In addition, enrichment analysis uncovered that CDCP1 was not only involved in multiple oncogenic pathways, but correlated with overexpression of immune checkpoints. Overall, we reported that increased expression of CDCP1 is a favorable prognostic factor in patients with BrCa. In addition, the correlations between CDCP1 and immune checkpoints provide a novel insight into the adjuvant treatment for immune checkpoint blockade via targeting CDCP1.


  • Open Access

    A Giant Borderline Phyllodes Tumor of Breast With Skin Ulceration Leading to Non-Insular Tumorigenic Hypoglycemia: A Case Report and Literature Review

    by Jinlu Zhao, Meizhuo Gao, Yi Ren, Shaodong Cao, He Wang, Ruisheng Ge

    Phyllodes tumor (PT) is a special type of breast tumors, including three types: malignant, borderline, and benign. Most of these tumors form unilateral disease and can rapidly increase in size. The occurrence of axillary lymph node metastasis is rare. Tumor-associated hypoglycemia can be divided into non-islet cell tumor and insulinoma. In non-islet cell tumor hypoglycemia (NICTH), a considerable high molecular weight form of insulin like growth factor 2 (IGF-2) is formed, which abnormally binds to insulin receptors in the tissues and causes hypoglycemia. Breast phyllodes tumors with NICTH are rare and first reported in 1983. Surgical resection is the main treatment and hypoglycemia symptoms usually resolve after surgery. Nevertheless, prior to surgery, intravenous glucose infusion is used to maintain blood glucose levels. A female patient presented with a rapidly growing breast mass and was diagnosed with a phyllodes tumor with NICTH at our hospital in August 2020; she was successfully treated through surgical resection. We reviewed the relevant literature to investigate and analyze the relationship between NICTH and phyllodes tumors, as well as optimize its diagnosis and treatment.


  • Open Access

    Fresh raspberry phytochemical extract inhibits hepatic lesion in a Wistar rat model

    by Yan Liu, Ming Liu, Bin Li, Jin-Lu Zhao, Chun-Peng Zhang, Luo-Qiang Lin, Hong-Sheng Chen, Shu-Jun Zhang, Jun-Chao Jin, Lei Wang, et al.

    Red raspberry possesses potent antioxidant capacity and antiproliferative activity against cancer in vitro.


  • Open Access

    Differential expression of proteomics models of colorectal cancer, colorectal benign disease and healthy controls

    by Ming Liu, Chun-Feng Li, Hong-Sheng Chen, Luo-Qiang Lin, Chun-Peng Zhang, Jin-Lu Zhao, Yan Liu, Shu-Jun Zhang, Jun-Chao Jin, Lei Wang, et al.

    Colorectal cancer (CRC) is often diagnosed at a late stage with concomitant poor prognosis. The hypersensitive analytical technique of proteomics can detect molecular changes before the tumor is palpable. The surface-enhanced laser desorption/ionization-time of flight-mass spectra (SELDI-TOF-MS) is a newly-developed technique of evaluating protein separation in recent years. The protein chips have established the expression of tumor protein in the serum specimens and become the newly discovered markers for tumor diagnosis. The objective of this study was to find new markers of the diagnosis among groups of CRC, colorectal benign diseases (CBD) and healthy controls. The assay of SELDI-TOF-MS with analytical technique of protein-chip bioinformatics was used to detect the expression of protein mass peaks in the sera of patients or controls. One hundred serum samples, including 52 cases of colorectal cancer, 27 cases of colorectal benign disease, and 21 cases of healthy controls, were examined by SELDI-TOF-MS with WCX2 protein-chips.